SCHEMBL25877898

SCHEMBL25877898

Cc1nc2c3ccccc3c3ccccc3c2nc1C(C)(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR3 P46089 1/20 0.41
ALDH1A1 P00352 7/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
CYP2A6 P11509 2/20 0.35
CYP1A2 P05177 3/20 0.33
ELANE P08246 2/20 0.33
HPGD P15428 2/20 0.33
HSD17B10 Q99714 2/20 0.33
NUDT1 P36639 1/20 0.33
MAPT P10636 2/20 0.33
MEN1 O00255 1/20 0.33
LMNA P02545 1/20 0.33
POLB P06746 1/20 0.33
PKM P14618 1/20 0.33
BLM P54132 1/20 0.33
KMT2A Q03164 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
ATM Q13315 1/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
KDM4E B2RXH2 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25817224 0.87 ALDH1A1 (0.44) GPR3ALDH1A1L3MBTL1CYP2A6CYP1A2
SCHEMBL18252753 0.80 GPR3 (0.52) GPR3ALDH1A1L3MBTL1CYP2A6CYP1A2
SCHEMBL20099325 0.77 ENPP1 (0.41) GPR3ALDH1A1L3MBTL1CYP2A6ELANE
SCHEMBL26051246 0.77 PRMT5 (0.42) GPR3ALDH1A1L3MBTL1CYP2A6CYP1A2
SCHEMBL25877958 0.77 PRMT5 (0.45) GPR3ALDH1A1L3MBTL1CYP2A6CYP1A2
SCHEMBL23473565 0.76 NUDT1 (0.38) ALDH1A1L3MBTL1HPGDHSD17B10NUDT1
SCHEMBL17445647 0.74 ENPP1 (0.42) GPR3ALDH1A1L3MBTL1CYP2A6ELANE
SCHEMBL16543252 0.73 ENPP1 (0.35) ALDH1A1L3MBTL1CYP1A2MEN1KMT2A
SCHEMBL14427995 0.72 ALDH1A1 (0.52) GPR3ALDH1A1L3MBTL1CYP1A2HPGD
SCHEMBL15745468 0.71 GPR3 (0.39) GPR3ALDH1A1L3MBTL1CYP2A6ELANE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230192669-A1 COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-06-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230192669-A1 COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS ACHE, OR51E2, L1CAM GPR3 3428/4885ALDH1A1 213/4885L3MBTL1 1994/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.